Drug Side Effects
Search
FUNGAL MYOSITIS
FUNGAL MYOSITIS
was reported 35 times
FUNGAL MYOSITIS is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Type I Interferon Receptor Antagonist [EPC]
1
0.0005
1
Bispecific CD20-directed CD3 T Cell Engager [EPC]
1
0.0002
2
Vitamin D3 Analog [EPC]
4
0.0002
3
Antimetabolite Immunosuppressant [EPC]
3
0.0001
4
Erythropoiesis-stimulating Agent [EPC]
5
0.0001
5
Insulin [EPC]
4
0.0001
6
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
4
0.0001
7
Lipid-based Polyene Antifungal [EPC]
1
0.0001
8
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
5
0.0001
9
Azole Antifungal [EPC]
7
0.0000
10
Programmed Death Receptor-1 Blocking Antibody [EPC]
3
0.0000
11
Penem Antibacterial [EPC]
1
0.0000
12
Polyene Antifungal [EPC]
1
0.0000
13
RANK Ligand Inhibitor [EPC]
5
0.0000
14
Alkylating Drug [EPC]
5
0.0000
15
Acetylcholine Release Inhibitor [EPC]
2
0.0000
16
Corticosteroid [EPC]
24
0.0000
17
Microtubule Inhibitor [EPC]
3
0.0000
18
Glycopeptide Antibacterial [EPC]
1
0.0000
19
Osmotic Laxative [EPC]
4
0.0000
20
Platinum-based Drug [EPC]
3
0.0000
21
CD20-directed Cytolytic Antibody [EPC]
3
0.0000
22
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]
1
0.0000
23
Insulin Analog [EPC]
4
0.0000
24
Loop Diuretic [EPC]
4
0.0000
25
Kinase Inhibitor [EPC]
4
0.0000
26
Tumor Necrosis Factor Blocker [EPC]
3
0.0000